Choate Investment Advisors - ARIAD PHARMACEUTICALS INC ownership

ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
Choate Investment Advisors ownership history of ARIAD PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2015$353,310,000
+195.9%
51,428
+151.5%
0.03%
+225.0%
Q3 2015$119,416,000
-61.9%
20,448
-46.0%
0.01%
-55.6%
Q2 2015$313,210,000
-7.1%
37,873
-7.5%
0.02%
-5.3%
Q1 2015$337,247,000
-4.5%
40,928
-20.4%
0.02%
-9.5%
Q4 2014$353,310,00051,4280.02%
Other shareholders
ARIAD PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Sarissa Capital Management LP 12,850,000$69,390,00026.80%
Opaleye Management Inc. 1,500,000$8,100,000,0006.31%
Camber Capital Management LP 6,000,000$32,400,0003.04%
Ghost Tree Capital, LLC 700,000$3,780,0002.05%
Granite Point Capital Management, L.P. 700,000$3,780,0001.88%
Duquesne Family Office 1,645,000$8,883,0001.09%
Geduld E E 272,200$1,470,0001.04%
Elk Creek Partners, LLC 659,232$3,560,0000.93%
Palo Alto Investors LP 2,231,717$12,051,0000.90%
HighVista Strategies LLC 1,200,000$6,480,0000.87%
View complete list of ARIAD PHARMACEUTICALS INC shareholders